J. B. Chemicals & Pharmaceuticals Limited

NSE JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2024: 27.08%

J. B. Chemicals & Pharmaceuticals Limited EBITDA Margin is 27.08% for the year ending March 31, 2024, a 21.06% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • J. B. Chemicals & Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2023 was 22.37%, a -6.76% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2022 was 23.99%, a -28.42% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2021 was 33.51%, a 39.61% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBITDA Margin for the year ending March 31, 2020 was 24.01%, a 11.60% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Loading...
SV Wall Street
NSE: JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

CEO Mr. Nikhil Ashokkumar Chopra
IPO Date July 1, 2002
Location India
Headquarters Cnergy IT Park
Employees 5,311
Sector Health Care
Industries
Description

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.

Similar companies

AJANTPHARM.NS

Ajanta Pharma Limited

USD 31.06

0.59%

IPCALAB.NS

Ipca Laboratories Limited

USD 16.64

-0.86%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 10.61

0.92%

ALKEM.NS

Alkem Laboratories Limited

USD 58.36

0.18%

NAVINFLUOR.NS

Navin Fluorine International Limited

USD 47.82

6.08%

StockViz Staff

February 1, 2025

Any question? Send us an email